the Web site, including, but not limited to Information originated by Zacks Intraday data delayed at least 15 minutes or per exchange requirements. The firm engages in the discovery, development, and commercializes of both small-molecule and … Please log in to your account or sign up in order to add this asset to your watchlist. Zacks Rank Education -- Learn more about the Zacks Rank
NYSE and AMEX data is at least 20 minutes delayed. Create a list of the investments you want to track. ), Omeros has received 505 “underperform” votes. 2 Since 1988 it has more than doubled the S&P 500 with an average gain of +24.44% per year. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Do Wall Street analysts recommend investors buy shares of Omeros?
Omeros has only been the subject of 3 research reports in the past 90 days. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. In the past three months, Omeros insiders have not sold or bought any company stock. This is an estimated date of earnings release.
It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Analysts Aren't Bullish on Factset Research Systems Stock…Is it a Contrarian Buy? OMER, Omeros Corp - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Based on an average trading volume of 1,320,000 shares, the days-to-cover ratio is presently 9.7 days. Research, Inc. nor its Information Providers can guarantee the accuracy,
This article will reflect on the compensation paid to Greg Demopulos who has served as CEO of Omeros Corporation... Kyle Dennis took a leap of faith and decided to invest his savings of $15K in the stock market — $2.8M later, he owes his success to these strategies. MarketBeat's community ratings are surveys of what our community members think about Omeros and other stocks. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. See rankings and related performance below. All Rights Reserved. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Discover historical prices for OMER stock on Yahoo Finance.
Omeros' stock was trading at $15.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. It's packed with all of the company's key stats and salient decision making information. Plus, OMER info will be updated daily in your Zacks.com Portfolio Tracker . Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. This suggests a possible upside of 108.3% from the stock's current price. Registration on or use of this site constitutes acceptance of our, Omeros (OMER) Catches Eye: Stock Jumps 6%, CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs, Omeros (OMER) Reports Q2 Loss, Lags Revenue Estimates, Stock Alert: Omeros Jumps To New 52-week High On Positive Narsoplimab Data. Fundamental company data provided by Morningstar and Zacks Investment Research.
The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. ], Omeros' COVID-19 Opportunity And Challenges, Omeros under pressure after pricing capital raises, Reata Slips On Update And Other News: The Good, Bad And Ugly Of Biopharma. .
Get daily stock ideas top-performing Wall Street analysts. Omeros Corporation OMER was a big mover last session, as the company saw its shares rise 6% on the day. Omeros has a market capitalization of $558.26 million and generates $111.81 million in revenue each year.
Omeros Corporation Common Stock (OMER) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Revenue) or per share (e.g.
The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. 5G has barely hit the market… And already there is something more powerful. See Zacks' prediction free. Omeros' mailing address is 201 ELLIOT AVENUE WEST, SEATTLE WA, 98119. Get real-time analyst ratings, earnings, dividends, headlines, insider trades, SEC filings and more.